Assessment of commercial SARS-CoV-2 antibody assays, Jamaica
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2020.09.27.20202655: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: This study was approved by the UWI Mona Campus Research Ethics Committee (ECP 244 19/20). Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sentences Resources The specificity panel included serum samples testing positive for Zika virus IgM, chikungunya virus IgM, dengue virus IgM, CMV IgM, CMV IgG, EBV IgM, parvovirus B19 IgM, anti-HTLV-I/II, HIV Ag/Ab, HBsAg, anti-HCV, convalescent samples from patients seroconverting for influenza A or B virus antibodies, convalescent samples from patients with respiratory disease but without seroconversion for influenza A and B … SciScore for 10.1101/2020.09.27.20202655: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: This study was approved by the UWI Mona Campus Research Ethics Committee (ECP 244 19/20). Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sentences Resources The specificity panel included serum samples testing positive for Zika virus IgM, chikungunya virus IgM, dengue virus IgM, CMV IgM, CMV IgG, EBV IgM, parvovirus B19 IgM, anti-HTLV-I/II, HIV Ag/Ab, HBsAg, anti-HCV, convalescent samples from patients seroconverting for influenza A or B virus antibodies, convalescent samples from patients with respiratory disease but without seroconversion for influenza A and B virus antibodies, healthy persons requesting vaccination status, and women seeking routine antenatal care (Supplementary Table). CMV IgM, CMV IgGsuggested: Noneanti-HTLV-I/IIsuggested: Noneanti-HCVsuggested: NoneSoftware and Algorithms Sentences Resources Data were analyzed using IBM SPSS Statistics® for Windows version 20. SPSSsuggested: (SPSS, RRID:SCR_002865)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-